Market Overview:
The global phenylbutazone market is expected to grow at a CAGR of 3.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of pain, increasing demand for analgesics and antipyretics drugs, and growing awareness about the benefits of phenylbutazone drugs. However, stringent regulatory norms for drug approvals are likely to restrain the growth of this market during the forecast period. On the basis of type, phenylbutazone is segmented into analgesia, antipyresis, and pain relief segments. The analgesia segment is expected to account for a major share in terms of revenue in 2018 owing to its high usage rates for treating various types of pain conditions. On the basis on application, phenylbutazone is used in humans (including pediatric patients), horses (including racehorses), and dogs segments.
Product Definition:
Phenylbutazone is a non-steroidal anti-inflammatory drug used to treat pain, fever, and inflammation. It is used for horses primarily as a pain reliever and anti-inflammatory.
Antipyresis:
Antipyresis is the interval between meals. It helps in maintaining blood glucose levels and weight loss by limiting food intake, especially in Syndrome X (polydipsia). The drug works by blunting appetite and promoting a feeling of fullness after a few hours of consumption.
Phenylbutazone is used to treat pain caused by osteoarthritis, rheumatoid arthritis or gout; it can also be used to reduce fever.
Analgesia:
Analgesia is the medical term used for pain relief. It's a drug induced state of mind wherein the body stops registering pain. Analgesics are mostly used to relieve pain caused by inflammation, surgery, and other conditions like arthritis. The most common types of analgesic drugs available in the market are non-narcotic and opioid analgesics.
Application Insights:
In humans, phenylbutazone is used for the treatment of various diseases such as acute pain, osteoarthritis pain, rheumatoid arthritis pain and fever. Acute pain was the major application segment in 2017 and is expected to witness a CAGR of XX% from 2018 to 2030 owing to increasing usage rates for this purpose across the globe. The drug has been found effective against neurogenic pains due largely on its anti-inflammatory property which reduces swelling and relieves pressure on nerve endings thus providing relief from chronic pains caused by sports injuries or carpal tunnel syndrome.
Regional Analysis:
North America phenylbutazone market accounted for the largest share of over 40.0% in 2017. The region is expected to maintain its dominance during the forecast period on account of rising product consumption in veterinary and human medicine, coupled with stringent regulatory framework governing drug safety. In addition, high prevalence of chronic pain conditions and widespread use of opioid-based analgesics are also contributing toward regional growth.
Asia Pacific is anticipated to be the fastest-growing region during the forecast period owing to increasing animal health awareness among pet owners coupled with rising expenditure on pet care products including vaccines, food & accessories, grooming services among others which are driving demand for drugs such as phenylbutazone in this region. Moreover, growing medical tourism industry due to low treatment cost is also expected to drive regional growth over the coming years (figure 1).
Growth Factors:
- Increasing demand for phenylbutazone in the veterinary market as a result of its anti-inflammatory and analgesic properties.
- Rising prevalence of chronic diseases, such as cancer and arthritis, which are treated with phenylbutazone.
- Growing awareness about the benefits of phenylbutazone among consumers and healthcare professionals.
- Availability of generic versions of phenylbutazone that offer lower prices than branded products.
Scope Of The Report
Report Attributes
Report Details
Report Title
Phenylbutazone Market Research Report
By Type
Antipyresis, Analgesia, Pain Relief
By Application
In Humans, In Horses, In Dogs
By Companies
Santa Cruz Biotechnology, Hangzhou Hyper Chemicals, Baoji Guokang Bio-Technology, Wuhan Yitongtai Science and Technology, Afine Chemicals, Shanghai Win-Win Biochemical, Shaanxi TOP Pharm Chemical, Hangzhou Hyper Chemicals, Hangzhou Ruijiang Chemical, Dalian Launcher Fine Chemical, Santa Cruz Biotechnology, Swati Chemicals, Suchem Laboratories, Afton Pharma, Hefei TNJ Chemical Industry
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
153
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global Phenylbutazone Market Report Segments:
The global Phenylbutazone market is segmented on the basis of:
Types
Antipyresis, Analgesia, Pain Relief
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
In Humans, In Horses, In Dogs
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Santa Cruz Biotechnology
- Hangzhou Hyper Chemicals
- Baoji Guokang Bio-Technology
- Wuhan Yitongtai Science and Technology
- Afine Chemicals
- Shanghai Win-Win Biochemical
- Shaanxi TOP Pharm Chemical
- Hangzhou Hyper Chemicals
- Hangzhou Ruijiang Chemical
- Dalian Launcher Fine Chemical
- Santa Cruz Biotechnology
- Swati Chemicals
- Suchem Laboratories
- Afton Pharma
- Hefei TNJ Chemical Industry
Highlights of The Phenylbutazone Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antipyresis
- Analgesia
- Pain Relief
- By Application:
- In Humans
- In Horses
- In Dogs
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Phenylbutazone Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Phenylbutazone is a medication used to treat pain and inflammation. It is also used to prevent or reduce the symptoms of arthritis.
Some of the major companies in the phenylbutazone market are Santa Cruz Biotechnology, Hangzhou Hyper Chemicals, Baoji Guokang Bio-Technology, Wuhan Yitongtai Science and Technology, Afine Chemicals, Shanghai Win-Win Biochemical, Shaanxi TOP Pharm Chemical, Hangzhou Hyper Chemicals, Hangzhou Ruijiang Chemical, Dalian Launcher Fine Chemical, Santa Cruz Biotechnology, Swati Chemicals, Suchem Laboratories, Afton Pharma, Hefei TNJ Chemical Industry.
The phenylbutazone market is expected to grow at a compound annual growth rate of 3.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Phenylbutazone Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Phenylbutazone Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Phenylbutazone Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Phenylbutazone Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Phenylbutazone Market Size & Forecast, 2020-2028
4.5.1 Phenylbutazone Market Size and Y-o-Y Growth
4.5.2 Phenylbutazone Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Antipyresis
5.2.2 Analgesia
5.2.3 Pain Relief
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 In Humans
6.2.2 In Horses
6.2.3 In Dogs
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Phenylbutazone Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Phenylbutazone Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Antipyresis
9.6.2 Analgesia
9.6.3 Pain Relief
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 In Humans
9.10.2 In Horses
9.10.3 In Dogs
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Antipyresis
10.6.2 Analgesia
10.6.3 Pain Relief
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 In Humans
10.10.2 In Horses
10.10.3 In Dogs
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Antipyresis
11.6.2 Analgesia
11.6.3 Pain Relief
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 In Humans
11.10.2 In Horses
11.10.3 In Dogs
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Antipyresis
12.6.2 Analgesia
12.6.3 Pain Relief
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 In Humans
12.10.2 In Horses
12.10.3 In Dogs
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Antipyresis
13.6.2 Analgesia
13.6.3 Pain Relief
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 In Humans
13.10.2 In Horses
13.10.3 In Dogs
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Phenylbutazone Market: Competitive Dashboard
14.2 Global Phenylbutazone Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Santa Cruz Biotechnology
14.3.2 Hangzhou Hyper Chemicals
14.3.3 Baoji Guokang Bio-Technology
14.3.4 Wuhan Yitongtai Science and Technology
14.3.5 Afine Chemicals
14.3.6 Shanghai Win-Win Biochemical
14.3.7 Shaanxi TOP Pharm Chemical
14.3.8 Hangzhou Hyper Chemicals
14.3.9 Hangzhou Ruijiang Chemical
14.3.10 Dalian Launcher Fine Chemical
14.3.11 Santa Cruz Biotechnology
14.3.12 Swati Chemicals
14.3.13 Suchem Laboratories
14.3.14 Afton Pharma
14.3.15 Hefei TNJ Chemical Industry
